- Home
- PLUG vs FTRE Comparison
PLUG vs FTRE Comparison
Compare PLUG & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLUG
- FTRE
- Stock Information
- Founded
- PLUG 1997
- FTRE 1996
- Country
- PLUG United States
- FTRE United States
- Employees
- PLUG 3868
- FTRE N/A
- Industry
- PLUG Industrial Machinery/Components
- FTRE Medical Specialities
- Sector
- PLUG Energy
- FTRE Health Care
- Exchange
- PLUG Nasdaq
- FTRE Nasdaq
- Market Cap
- PLUG 1.6B
- FTRE 1.4B
- IPO Year
- PLUG 1999
- FTRE N/A
- Fundamental
- Price
- PLUG $1.66
- FTRE $14.88
- Analyst Decision
- PLUG Hold
- FTRE Hold
- Analyst Count
- PLUG 16
- FTRE 11
- Target Price
- PLUG $3.03
- FTRE $23.30
- AVG Volume (30 Days)
- PLUG 59.8M
- FTRE 1.2M
- Earning Date
- PLUG 03-04-2025
- FTRE 03-03-2025
- Dividend Yield
- PLUG N/A
- FTRE N/A
- EPS Growth
- PLUG N/A
- FTRE N/A
- EPS
- PLUG N/A
- FTRE N/A
- Revenue
- PLUG $659,505,000.00
- FTRE $2,975,600,000.00
- Revenue This Year
- PLUG N/A
- FTRE N/A
- Revenue Next Year
- PLUG $26.88
- FTRE $1.02
- P/E Ratio
- PLUG N/A
- FTRE N/A
- Revenue Growth
- PLUG N/A
- FTRE 2.80
- 52 Week Low
- PLUG $1.57
- FTRE $14.27
- 52 Week High
- PLUG $4.90
- FTRE $41.02
- Technical
- Relative Strength Index (RSI)
- PLUG 36.75
- FTRE 34.60
- Support Level
- PLUG $1.57
- FTRE $14.88
- Resistance Level
- PLUG $1.85
- FTRE $15.83
- Average True Range (ATR)
- PLUG 0.13
- FTRE 0.69
- MACD
- PLUG 0.01
- FTRE 0.08
- Stochastic Oscillator
- PLUG 19.57
- FTRE 25.85
About PLUG Plug Power Inc.
Plug Power is building an end-to-end green hydrogen ecosystem-from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.